SARS-CoV-2 antibody seroconversion in care home
- PMID: 33009507
- PMCID: PMC7530877
- DOI: 10.1038/s41577-020-00463-1
SARS-CoV-2 antibody seroconversion in care home
Comment on
-
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).BMJ. 2020 Oct 22;371:m3939. doi: 10.1136/bmj.m3939. BMJ. 2020. PMID: 33093056 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous